DK1173210T3 - Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin - Google Patents

Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin

Info

Publication number
DK1173210T3
DK1173210T3 DK00928611T DK00928611T DK1173210T3 DK 1173210 T3 DK1173210 T3 DK 1173210T3 DK 00928611 T DK00928611 T DK 00928611T DK 00928611 T DK00928611 T DK 00928611T DK 1173210 T3 DK1173210 T3 DK 1173210T3
Authority
DK
Denmark
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
DK00928611T
Other languages
English (en)
Inventor
Lin Zhi
Todd K Jones
James P Edwards
Jay E Wrobel
Gary S Grubb
Christopher M Tegley
Horace A Fletcher
Andrew Fensome
Puwen Zhang
Eugene A Terefenko
Original Assignee
Wyeth Corp
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by Wyeth Corp, Ligand Pharm Inc filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1173210T3 publication Critical patent/DK1173210T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK00928611T 1999-05-04 2000-05-01 Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin DK1173210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators

Publications (1)

Publication Number Publication Date
DK1173210T3 true DK1173210T3 (da) 2005-01-24

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00928611T DK1173210T3 (da) 1999-05-04 2000-05-01 Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin

Country Status (14)

Country Link
EP (1) EP1173210B1 (da)
JP (1) JP2002543155A (da)
CN (1) CN1179753C (da)
AT (1) ATE275973T1 (da)
AU (1) AU4682000A (da)
CA (1) CA2372773A1 (da)
DE (1) DE60013798T2 (da)
DK (1) DK1173210T3 (da)
ES (1) ES2226833T3 (da)
HK (1) HK1043736B (da)
MX (1) MXPA01011311A (da)
PT (1) PT1173210E (da)
SI (1) SI1173210T1 (da)
WO (1) WO2000066164A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1699A (en) 2001-03-21 2006-12-26 Warner Lambert Co New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EP1558618A1 (en) 2002-10-11 2005-08-03 Ligand Pharmaceuticals, Inc. 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
WO2004033460A1 (en) 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
AR047398A1 (es) * 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
MXPA06012403A (es) * 2004-04-27 2007-01-17 Wyeth Corp Purificacion de moduladores de receptor progesterona.
WO2006010142A2 (en) * 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
DE69532894T2 (de) * 1994-11-22 2004-09-02 Balance Pharmaceuticals, Inc., Pacific Palisades Verfahren zur empfängnisverhütung
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
JP2000514785A (ja) * 1996-06-25 2000-11-07 アクゾ・ノベル・エヌ・ベー プロゲストゲン―抗プロゲストゲン処方

Also Published As

Publication number Publication date
CN1179753C (zh) 2004-12-15
AU4682000A (en) 2000-11-17
MXPA01011311A (es) 2003-07-14
WO2000066164A8 (en) 2001-05-03
SI1173210T1 (en) 2005-02-28
WO2000066164A1 (en) 2000-11-09
CA2372773A1 (en) 2000-11-09
EP1173210A1 (en) 2002-01-23
DE60013798T2 (de) 2005-09-29
DE60013798D1 (de) 2004-10-21
EP1173210B1 (en) 2004-09-15
ES2226833T3 (es) 2005-04-01
CN1349415A (zh) 2002-05-15
HK1043736A1 (en) 2002-09-27
PT1173210E (pt) 2005-01-31
JP2002543155A (ja) 2002-12-17
ATE275973T1 (de) 2004-10-15
HK1043736B (zh) 2005-04-01

Similar Documents

Publication Publication Date Title
WO2000066165A8 (en) Contraceptive compositions containing quinazolinone and benzoxazine derivatives
DK1175398T3 (da) Indolinderivater som progesteronantagonister
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
WO2000066225A8 (en) Contraceptive compositions containing cyclic carbamates and amide derivatives
WO2000066103A3 (en) Contraceptive compositions containing cyclic urea and amide derivatives
ITRM20010356A1 (it) "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
HUP0002461A2 (hu) Triciklusos benzotiepin- vagy benzoxepinszármazékok és ezeket tartalmazó gyógyszerkészítmények
DK1173210T3 (da) Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin
BR0311593A (pt) Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc
BR9811769A (pt) Tetraidro gama-carbolinas
HUP0203332A2 (hu) Ciklotiokarbamát-származékok, progeszteron receptor modulátorokként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE460412T1 (de) Trisubstituierte thiophene als progesteronreceptor-modulatoren
NO992676L (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators
TR200002831A2 (tr) Kinolin-4-İl türevleri I
EA200101180A1 (ru) Производные тио-оксиндола
ATE412631T1 (de) Indolderivate als progesteron-rezeptormodulatoren
BR0010213A (pt) Derivados de ciclocarbamato como moduladores de receptor de progesterona
AR023854A1 (es) Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos
AR024549A1 (es) Uso de moduladores de progesterona del receptor de progesterona y kit farmaceutica para regimenes ciclicos
AR030018A1 (es) Derivados de benzo(d)(1,3)oxazin-2-ona, composiciones farmaceuticas que los comprenden y el uso de los mismos para preparar medicamentos como moduladores receptores de progesterona